Streetbeat News

Price Targets

VERA

JP Morgan analyst Anupam Rama has maintained an Overweight rating on Vera Therapeutics (NASDAQ:VERA) but reduced the price target from $25 to $22.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:31 pm

UNH

Truist Securities analyst David Macdonald has reiterated a Buy rating on UnitedHealth Group (NYSE:UNH) and maintained a price target of $610.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:30 pm

PSTG

JP Morgan analyst Pinjalim Bora has maintained an Overweight rating on Pure Storage (NYSE:PSTG) but reduced the price target from $45 to $40.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:29 pm

NCNO

Truist Securities analyst Terry Tillman has reaffirmed a Buy rating on nCino (NASDAQ: NCNO) but reduced the price target from $40 to $37.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:28 pm

DLTR

JP Morgan analyst Matthew Boss has maintained a Neutral rating on Dollar Tree (NASDAQ:DLTR) and reduced the price target from $125 to $122.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:22 pm

AEE

JP Morgan analyst Jeremy Metz has maintained an Overweight rating on Ameren (NYSE:AEE) but has reduced the price target from $90 to $89.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:21 pm

SNOW

Truist Securities analyst Joel Fishbein has maintained a Buy rating on Snowflake (NYSE:SNOW) and increased the price target from $200 to $210.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:21 pm

ZLAB

JP Morgan analyst Anupam Rama has maintained an Overweight rating on Zai Lab (NASDAQ:ZLAB) and increased the price target from $64 to $66.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:20 pm

XEL

JP Morgan analyst Jeremy Metz has maintained a Neutral rating on Xcel Energy (NASDAQ:XEL) and increased the price target from $66 to $68.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:19 pm

QS

Truist Securities analyst Jordan Levy has maintained a Hold rating on QuantumScape (NYSE:QS) and increased the price target from $6 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:18 pm